S 5732 119th Congress

A bill to amend the 21st Century Cures Act and the Public Health Service Act to ensure that expenses relating to the acquisition or use of devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances, including test strips, are allowable expenses under certain grant programs.

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Congress.gov

Sponsors

Actions

2026-11-17T00:00:00

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2026-11-17T00:00:00

Introduced in Senate

Policy Areas

Track this bill on CivicBeacon

Get push notifications when this bill is updated, contact your reps, and take action.

Download on the App Store Get it on Google Play